Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Development and validation of a luminescence-based, medium-throughput assay for drug screening in Schistosoma mansoni.

Lalli C, Guidi A, Gennari N, Altamura S, Bresciani A, Ruberti G.

PLoS Negl Trop Dis. 2015 Jan 30;9(1):e0003484. doi: 10.1371/journal.pntd.0003484. eCollection 2015 Jan.

2.

Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells.

Montagner G, Gemmo C, Fabbri E, Manicardi A, Accardo I, Bianchi N, Finotti A, Breveglieri G, Salvatori F, Borgatti M, Lampronti I, Bresciani A, Altamura S, Corradini R, Gambari R.

Int J Mol Med. 2015 Jan;35(1):51-8. doi: 10.3892/ijmm.2014.2005. Epub 2014 Nov 14.

3.

Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey.

Berisso MZ, Fabbri G, Gonzini L, Caruso D, Fontanella A, Pellegrini F, Silvestri N, Vincenti A, Mathieu G, Di Pasquale G; ATA-AF Investigators.

J Cardiovasc Med (Hagerstown). 2014 Aug;15(8):626-35. doi: 10.2459/JCM.0000000000000110.

PMID:
24978662
4.

Medication non-adherence among elderly patients newly discharged and receiving polypharmacy.

Pasina L, Brucato AL, Falcone C, Cucchi E, Bresciani A, Sottocorno M, Taddei GC, Casati M, Franchi C, Djade CD, Nobili A.

Drugs Aging. 2014 Apr;31(4):283-9. doi: 10.1007/s40266-014-0163-7.

PMID:
24604085
5.

Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy.

Violi F, Daví G, Hiatt W, Lip GY, Corazza GR, Perticone F, Proietti M, Pignatelli P, Vestri AR, Basili S; ARAPACIS Study Investigators.

J Am Coll Cardiol. 2013 Dec 10;62(23):2255-6. doi: 10.1016/j.jacc.2013.07.035. Epub 2013 Aug 14. No abstract available.

6.

Decision making for oral anticoagulants in atrial fibrillation: the ATA-AF study.

Gussoni G, Di Pasquale G, Vescovo G, Gulizia M, Mathieu G, Scherillo M, Panuccio D, Lucci D, Nozzoli C, Fabbri G, Colombo F, Riva L, Baldo CI, Maggioni AP, Mazzone A; ATA-AF Steering Committee and Investigators.

Eur J Intern Med. 2013 Jun;24(4):324-32. doi: 10.1016/j.ejim.2013.04.008. Epub 2013 May 16.

PMID:
23684591
7.

Enteral vs. intravenous ICU sedation management: study protocol for a randomized controlled trial.

Mistraletti G, Mantovani ES, Cadringher P, Cerri B, Corbella D, Umbrello M, Anania S, Andrighi E, Barello S, Di Carlo A, Martinetti F, Formenti P, Spanu P, Iapichino G; SedaEN investigators.

Trials. 2013 Apr 3;14:92. doi: 10.1186/1745-6215-14-92.

8.

Mortality after surgery in Europe: a 7 day cohort study.

Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, Vallet B, Vincent JL, Hoeft A, Rhodes A; European Surgical Outcomes Study (EuSOS) group for the Trials groups of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology.

Lancet. 2012 Sep 22;380(9847):1059-65. doi: 10.1016/S0140-6736(12)61148-9.

9.

Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study.

Di Pasquale G, Mathieu G, Maggioni AP, Fabbri G, Lucci D, Vescovo G, Pirelli S, Chiarella F, Scherillo M, Gulizia MM, Gussoni G, Colombo F, Panuccio D, Nozzoli C, Berisso MZ; ATA-AF Investigators.

Int J Cardiol. 2013 Sep 10;167(6):2895-903. doi: 10.1016/j.ijcard.2012.07.019. Epub 2012 Aug 11.

PMID:
22884698
10.

Peri-procedural tight glycemic control during early percutaneous coronary intervention is associated with a lower rate of in-stent restenosis in patients with acute ST-elevation myocardial infarction.

Marfella R, Sasso FC, Siniscalchi M, Paolisso P, Rizzo MR, Ferraro F, Stabile E, Sorropago G, Calabrò P, Carbonara O, Cinquegrana G, Piscione F, Ruocco A, D'Andrea D, Rapacciuolo A, Petronella P, Bresciani A, Rubino P, Mauro C, Paolisso G.

J Clin Endocrinol Metab. 2012 Aug;97(8):2862-71. doi: 10.1210/jc.2012-1364. Epub 2012 May 25.

PMID:
22639289
11.

A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins.

Grifantini R, Pagani M, Pierleoni A, Grandi A, Parri M, Campagnoli S, Pileri P, Cattaneo D, Canidio E, Pontillo A, De Camilli E, Bresciani A, Marinoni F, Pedrazzoli E, Nogarotto R, Abrignani S, Viale G, Sarmientos P, Grandi G.

J Proteomics. 2011 Dec 21;75(2):532-47. doi: 10.1016/j.jprot.2011.08.018. Epub 2011 Sep 5.

PMID:
21920474
12.

Identification of a series of 4-[3-(quinolin-2-yl)-1,2,4-oxadiazol-5-yl]piperazinyl ureas as potent smoothened antagonist hedgehog pathway inhibitors.

Ontoria JM, Bufi LL, Torrisi C, Bresciani A, Giomini C, Rowley M, Serafini S, Bin H, Hao W, Steinkühler C, Jones P.

Bioorg Med Chem Lett. 2011 Sep 15;21(18):5274-82. doi: 10.1016/j.bmcl.2011.07.031. Epub 2011 Jul 14.

PMID:
21803580
13.

N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists.

Muraglia E, Ontoria JM, Branca D, Dessole G, Bresciani A, Fonsi M, Giuliano C, Llauger Bufi L, Monteagudo E, Palumbi MC, Torrisi C, Rowley M, Steinkühler C, Jones P.

Bioorg Med Chem Lett. 2011 Sep 15;21(18):5283-8. doi: 10.1016/j.bmcl.2011.07.030. Epub 2011 Jul 14.

PMID:
21802943
14.

Rhombencephalitis caused by Listeria monocytogenes with striking involvement of trigeminal nerve on MR imaging.

Moro A, Albino PH, Bresciani AP, Oliveira MV, Bertotti MM, Ferreira RM, Queiroz LP.

Arq Neuropsiquiatr. 2011 Jun;69(3):568-9. No abstract available.

15.

Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis.

Fortugno P, Bresciani A, Paolini C, Pazzagli C, El Hachem M, D'Alessio M, Zambruno G.

J Invest Dermatol. 2011 Nov;131(11):2223-32. doi: 10.1038/jid.2011.174. Epub 2011 Jun 23.

16.

Comparison of two diets of varying glycemic index on carotid subclinical atherosclerosis in obese children.

Iannuzzi A, Licenziati MR, Vacca M, De Marco D, Cinquegrana G, Laccetti M, Bresciani A, Covetti G, Iannuzzo G, Rubba P, Parillo M.

Heart Vessels. 2009 Nov;24(6):419-24. doi: 10.1007/s00380-008-1138-6. Epub 2009 Nov 22.

PMID:
20108073
17.

Carotid artery wall hypertrophy in children with metabolic syndrome.

Iannuzzi A, Licenziati MR, Acampora C, De Michele M, Iannuzzo G, Chiariello G, Covetti G, Bresciani A, Romano L, Panico S, Rubba P.

J Hum Hypertens. 2008 Feb;22(2):83-8. Epub 2007 Oct 11.

PMID:
17928879
18.

Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia.

Migliaresi S, Bresciani A, Ambrosone L, Spera M, Barbarulo D, Lombari V, Pirozzi G, Borgia G, Lombardi ML, Tirri G, Manzo C.

Ann Rheum Dis. 2000 Jan;59(1):20-5.

19.

Increased level of serum HLA class I antigens in patients with systemic lupus in patients with systemic lupus erythematosus. Correlation with disease activity.

Bresciani A, Pirozzi G, Spera M, Lombardi ML, Ambrosone L, Migliaresi S, Ferrone S, Manzo C.

Tissue Antigens. 1998 Jul;52(1):44-50.

PMID:
9714473
20.

Vibrio cholerae 01 isolated in the gallbladder of a patient presenting with cholecystitis.

Asnis DS, Golub R, Bresciani A.

Am J Gastroenterol. 1996 Oct;91(10):2241-2.

PMID:
8855762
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk